ID   KCMA1_RAT               Reviewed;        1209 AA.
AC   Q62976; O08626; O55180; O88659; Q7TMZ7; Q7TMZ8; Q7TQ55; Q7TQ56; Q7TQ57;
AC   Q9WUI3;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-FEB-2008, sequence version 3.
DT   02-OCT-2024, entry version 192.
DE   RecName: Full=Calcium-activated potassium channel subunit alpha-1;
DE   AltName: Full=BK channel;
DE   AltName: Full=BKCA alpha;
DE   AltName: Full=Calcium-activated potassium channel, subfamily M subunit alpha-1;
DE   AltName: Full=K(VCA)alpha;
DE   AltName: Full=KCa1.1;
DE   AltName: Full=Maxi K channel;
DE            Short=MaxiK;
DE   AltName: Full=Slo-alpha;
DE   AltName: Full=Slo1;
DE   AltName: Full=Slowpoke homolog;
DE            Short=Slo homolog;
GN   Name=Kcnma1; Synonyms=Kcnma;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND TRANSPORTER ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Aortic smooth muscle;
RX   PubMed=9403560; DOI=10.1161/01.hyp.30.6.1403;
RA   Liu Y., Pleyte K., Knaus H.-G., Rusch N.J.;
RT   "Increased expression of Ca2+-sensitive K+ channels in aorta of
RT   hypertensive rats.";
RL   Hypertension 30:1403-1409(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TRANSPORTER ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=10651830; DOI=10.1046/j.1432-1327.2000.01076.x;
RA   Ha T.S., Jeong S.Y., Cho S.-W., Jeon H.-K., Roh G.S., Choi W.S.,
RA   Park C.-S.;
RT   "Functional characteristics of two BKCa channel variants differentially
RT   expressed in rat brain tissues.";
RL   Eur. J. Biochem. 267:910-918(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   STRAIN=Sprague-Dawley; TISSUE=Brain cortex;
RA   Reimann F.;
RL   Submitted (NOV-1995) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RC   STRAIN=Wistar HsdOla; TISSUE=Myometrium;
RA   Lawrence K.M., Fenech C.J., Zhang H., Bolton T.B.;
RT   "Cloning and expression of smooth muscle specific isoforms of a rat
RT   calcium-activated potassium channel.";
RL   Submitted (APR-1996) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1028 (ISOFORM 6).
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10384881;
RX   DOI=10.1002/(sici)1098-1136(199904)26:2<166::aid-glia7>3.0.co;2-q;
RA   Mi H., Harris-Warrick R.M., Deerinck T.J., Inman I., Ellisman M.H.,
RA   Schwarz T.L.;
RT   "Identification and localization of Ca(2+)-activated K+ channels in rat
RT   sciatic nerve.";
RL   Glia 26:166-175(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 62-1209 (ISOFORM 2), ACTIVITY REGULATION,
RP   MUTAGENESIS OF 685-CYS-HIS-686, FUNCTION, AND TRANSPORTER ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Cerebral artery;
RX   PubMed=16166559; DOI=10.1161/01.res.0000186180.47148.7b;
RA   Jaggar J.H., Li A., Parfenova H., Liu J., Umstot E.S., Dopico A.M.,
RA   Leffler C.W.;
RT   "Heme is a carbon monoxide receptor for large-conductance Ca2+-activated K+
RT   channels.";
RL   Circ. Res. 97:805-812(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 62-1209 (ISOFORMS 2 AND 5).
RC   STRAIN=Sprague-Dawley; TISSUE=Aorta, and Cerebral artery;
RA   Liu J., Asuncion-Chin M.T., Liu P., Dopico A.M.;
RT   "Slo subunits cloned from freshly isolated rat cerebral artery myocytes.";
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   ALTERNATIVE SPLICING (ISOFORM 7), AND SUBCELLULAR LOCATION (ISOFORM 7).
RX   PubMed=11278440; DOI=10.1074/jbc.m008852200;
RA   Zarei M.M., Zhu N., Alioua A., Eghbali M., Stefani E., Toro L.;
RT   "A novel MaxiK splice variant exhibits dominant-negative properties for
RT   surface expression.";
RL   J. Biol. Chem. 276:16232-16239(2001).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-712; SER-925 AND SER-929, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Potassium channel activated by both membrane depolarization
CC       or increase in cytosolic Ca(2+) that mediates export of K(+). It is
CC       also activated by the concentration of cytosolic Mg(2+). Its activation
CC       dampens the excitatory events that elevate the cytosolic Ca(2+)
CC       concentration and/or depolarize the cell membrane. It therefore
CC       contributes to repolarization of the membrane potential. Plays a key
CC       role in controlling excitability in a number of systems, such as
CC       regulation of the contraction of smooth muscle, the tuning of hair
CC       cells in the cochlea, regulation of transmitter release, and innate
CC       immunity. In smooth muscles, its activation by high level of Ca(2+),
CC       caused by ryanodine receptors in the sarcoplasmic reticulum, regulates
CC       the membrane potential. In cochlea cells, its number and kinetic
CC       properties partly determine the characteristic frequency of each hair
CC       cell and thereby helps to establish a tonotopic map. Kinetics of KCNMA1
CC       channels are determined by alternative splicing, phosphorylation status
CC       and its combination with modulating beta subunits. Highly sensitive to
CC       both iberiotoxin (IbTx) and charybdotoxin (CTX).
CC       {ECO:0000269|PubMed:10651830}.
CC   -!- FUNCTION: [Isoform 2]: Potassium channel activated by both membrane
CC       depolarization or increase in cytosolic Ca(2+) that mediates export of
CC       K(+). {ECO:0000269|PubMed:16166559, ECO:0000269|PubMed:9403560}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:10651830};
CC   -!- CATALYTIC ACTIVITY: [Isoform 2]:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:16166559, ECO:0000269|PubMed:9403560};
CC   -!- ACTIVITY REGULATION: Ethanol and carbon monoxide-bound heme increase
CC       channel activation. {ECO:0000250|UniProtKB:Q12791}.
CC   -!- ACTIVITY REGULATION: [Isoform 2]: Heme inhibits channel activation.
CC       {ECO:0000269|PubMed:16166559}.
CC   -!- SUBUNIT: Homotetramer; which constitutes the calcium-activated
CC       potassium channel. Interacts with beta subunits KCNMB1, KCNMB2, KCNMB3
CC       and KCNMB4. Interacts with gamma subunits LRRC26, LRRC38, LRRC52 and
CC       LRRC55. Beta and gamma subunits are accessory, and modulate its
CC       activity. Interacts with RAB11B (By similarity).
CC       {ECO:0000250|UniProtKB:Q08460, ECO:0000250|UniProtKB:Q12791}.
CC   -!- INTERACTION:
CC       Q62976; P02688: Mbp; NbExp=4; IntAct=EBI-1638146, EBI-1638296;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q12791};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 7]: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11278440}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Has a dominant-negative effect on other isoforms,
CC       preventing their localization to the cell membrane.
CC       {ECO:0000269|PubMed:11278440}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=May be partially controlled by hormonal stress. Additional
CC         isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q62976-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, C, cvb1, cvb2;
CC         IsoId=Q62976-2; Sequence=VSP_009970, VSP_009973, VSP_009976;
CC       Name=3;
CC         IsoId=Q62976-3; Sequence=VSP_009970, VSP_009973, VSP_009976,
CC                                  VSP_009982;
CC       Name=4; Synonyms=STTEX;
CC         IsoId=Q62976-8; Sequence=VSP_009974, VSP_009976;
CC       Name=5; Synonyms=A;
CC         IsoId=Q62976-9; Sequence=VSP_009973, VSP_009976, VSP_009978,
CC                                  VSP_009979;
CC       Name=6; Synonyms=SLON-1;
CC         IsoId=Q62976-10; Sequence=VSP_009970, VSP_009976;
CC       Name=7; Synonyms=SV1;
CC         IsoId=Q62976-11; Sequence=VSP_009971;
CC   -!- DOMAIN: The S0 segment is essential for the modulation by the accessory
CC       beta subunits KCNMB1, KCNMB2, KCNMB3 and KCNMB4.
CC       {ECO:0000250|UniProtKB:Q12791}.
CC   -!- DOMAIN: The S4 segment, which is characterized by a series of
CC       positively charged amino acids at every third position, is part of the
CC       voltage-sensor. {ECO:0000250|UniProtKB:Q12791}.
CC   -!- DOMAIN: The pore-forming domain (also referred as P region) is imbedded
CC       into the membrane, and forms the selectivity filter of the pore. It
CC       contains the signature sequence of potassium channels that displays
CC       selectivity to potassium (By similarity).
CC       {ECO:0000250|UniProtKB:Q12791}.
CC   -!- DOMAIN: The RCK N-terminal domain mediates the homotetramerization,
CC       thereby promoting the assembly of monomers into functional potassium
CC       channel. It includes binding sites for Ca(2+) and Mg(2+) (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: The heme-binding motif mediates inhibition of channel
CC       activation by heme. Carbon monoxide-bound heme leads to increased
CC       channel activation. {ECO:0000250|UniProtKB:Q12791}.
CC   -!- DOMAIN: The calcium bowl constitutes one of the Ca(2+) sensors and
CC       probably acts as a Ca(2+)-binding site. There are however other Ca(2+)
CC       sensor regions required for activation of the channel.
CC       {ECO:0000250|UniProtKB:B7ZC96}.
CC   -!- PTM: Phosphorylated (Probable). Phosphorylation by kinases such as PKA
CC       and/or PKG. In smooth muscles, phosphorylation affects its activity (By
CC       similarity). {ECO:0000250|UniProtKB:Q12791, ECO:0000305}.
CC   -!- PTM: Palmitoylation by ZDHHC22 and ZDHHC23 within the intracellular
CC       linker between the S0 and S1 transmembrane domains regulates
CC       localization to the plasma membrane. Depalmitoylated by LYPLA1 and
CC       LYPLAL1, leading to retard exit from the trans-Golgi network (By
CC       similarity). {ECO:0000250|UniProtKB:Q12791}.
CC   -!- MISCELLANEOUS: The protein was initially thought to contain two
CC       functionally distinct parts: The core channel (from the N-terminus to
CC       the S9 segment) that mediates the channel activity, and the cytoplasmic
CC       tail (from the S9 segment to the C-terminus) that mediates the calcium
CC       sensing. The situation is however more complex, since the core channel
CC       contains binding sites for Ca(2+) and Mg(2+).
CC   -!- SIMILARITY: Belongs to the potassium channel family. Calcium-activated
CC       (TC 1.A.1.3) subfamily. KCa1.1/KCNMA1 sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB51398.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U93052; AAB51398.1; ALT_FRAME; mRNA.
DR   EMBL; AF135265; AAD34786.1; -; mRNA.
DR   EMBL; U40603; AAB96356.1; -; mRNA.
DR   EMBL; U55995; AAA99161.1; -; mRNA.
DR   EMBL; AF083341; AAC32866.1; -; mRNA.
DR   EMBL; AY330290; AAP82450.1; -; mRNA.
DR   EMBL; AY330291; AAP82451.1; -; mRNA.
DR   EMBL; AY330292; AAP82452.1; -; mRNA.
DR   EMBL; AY330293; AAP82453.2; -; mRNA.
DR   EMBL; AY330294; AAP82454.1; -; mRNA.
DR   RefSeq; NP_114016.1; NM_031828.1.
DR   AlphaFoldDB; Q62976; -.
DR   SMR; Q62976; -.
DR   BioGRID; 249823; 5.
DR   CORUM; Q62976; -.
DR   DIP; DIP-40510N; -.
DR   IntAct; Q62976; 43.
DR   MINT; Q62976; -.
DR   STRING; 10116.ENSRNOP00000058962; -.
DR   BindingDB; Q62976; -.
DR   ChEMBL; CHEMBL5505; -.
DR   GuidetoPHARMACOLOGY; 380; -.
DR   TCDB; 1.A.1.3.2; the voltage-gated ion channel (vic) superfamily.
DR   iPTMnet; Q62976; -.
DR   PhosphoSitePlus; Q62976; -.
DR   SwissPalm; Q62976; -.
DR   PaxDb; 10116-ENSRNOP00000058962; -.
DR   ABCD; Q62976; 3 sequenced antibodies.
DR   Ensembl; ENSRNOT00000066928.4; ENSRNOP00000061684.3; ENSRNOG00000005985.9. [Q62976-3]
DR   GeneID; 83731; -.
DR   KEGG; rno:83731; -.
DR   AGR; RGD:620715; -.
DR   CTD; 3778; -.
DR   RGD; 620715; Kcnma1.
DR   VEuPathDB; HostDB:ENSRNOG00000005985; -.
DR   GeneTree; ENSGT00940000154935; -.
DR   InParanoid; Q62976; -.
DR   OrthoDB; 2902976at2759; -.
DR   PhylomeDB; Q62976; -.
DR   Reactome; R-RNO-1296052; Ca2+ activated K+ channels.
DR   PRO; PR:Q62976; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000005985; Expressed in frontal cortex and 14 other cell types or tissues.
DR   ExpressionAtlas; Q62976; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0005901; C:caveola; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; ISO:RGD.
DR   GO; GO:0048787; C:presynaptic active zone membrane; IDA:RGD.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0016528; C:sarcoplasm; ISO:RGD.
DR   GO; GO:0043195; C:terminal bouton; ISO:RGD.
DR   GO; GO:0008076; C:voltage-gated potassium channel complex; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; ISO:RGD.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0060072; F:large conductance calcium-activated potassium channel activity; IDA:RGD.
DR   GO; GO:0099507; F:ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0005267; F:potassium channel activity; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0005249; F:voltage-gated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0007628; P:adult walking behavior; ISO:RGD.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; IDA:RGD.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0002069; P:columnar/cuboidal epithelial cell maturation; ISO:RGD.
DR   GO; GO:0060082; P:eye blink reflex; ISO:RGD.
DR   GO; GO:0042491; P:inner ear auditory receptor cell differentiation; ISO:RGD.
DR   GO; GO:0030007; P:intracellular potassium ion homeostasis; ISO:RGD.
DR   GO; GO:0045475; P:locomotor rhythm; ISO:RGD.
DR   GO; GO:0060073; P:micturition; ISO:RGD.
DR   GO; GO:0045794; P:negative regulation of cell volume; ISO:RGD.
DR   GO; GO:1904348; P:negative regulation of small intestine smooth muscle contraction; IMP:RGD.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; ISO:RGD.
DR   GO; GO:0042551; P:neuron maturation; ISO:RGD.
DR   GO; GO:0019228; P:neuronal action potential; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; IMP:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0006813; P:potassium ion transport; ISO:RGD.
DR   GO; GO:0032344; P:regulation of aldosterone metabolic process; ISO:RGD.
DR   GO; GO:0042391; P:regulation of membrane potential; ISO:RGD.
DR   GO; GO:0060087; P:relaxation of vascular associated smooth muscle; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IDA:RGD.
DR   GO; GO:0034465; P:response to carbon monoxide; ISO:RGD.
DR   GO; GO:0043627; P:response to estrogen; IDA:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IDA:RGD.
DR   GO; GO:0006970; P:response to osmotic stress; ISO:RGD.
DR   GO; GO:0009268; P:response to pH; IDA:RGD.
DR   GO; GO:0046541; P:saliva secretion; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISO:RGD.
DR   GO; GO:0060083; P:smooth muscle contraction involved in micturition; ISO:RGD.
DR   GO; GO:0042311; P:vasodilation; IMP:RGD.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 2.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR003929; K_chnl_BK_asu.
DR   InterPro; IPR047871; K_chnl_Slo-like.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR048735; Slowpoke-like_C.
DR   PANTHER; PTHR10027; CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA CHAIN; 1.
DR   PANTHER; PTHR10027:SF28; CALCIUM-ACTIVATED POTASSIUM CHANNEL SUBUNIT ALPHA-1; 1.
DR   Pfam; PF03493; BK_channel_a; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   Pfam; PF22614; Slo-like_RCK; 2.
DR   Pfam; PF21014; Slowpoke_C; 1.
DR   PRINTS; PR01449; BKCHANNELA.
DR   PRINTS; PR00169; KCHANNEL.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
DR   PROSITE; PS51201; RCK_N; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell membrane; Endoplasmic reticulum;
KW   Ion channel; Ion transport; Lipoprotein; Magnesium; Membrane;
KW   Metal-binding; Palmitate; Phosphoprotein; Potassium; Potassium channel;
KW   Potassium transport; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..1209
FT                   /note="Calcium-activated potassium channel subunit alpha-1"
FT                   /id="PRO_0000054137"
FT   TOPO_DOM        1..87
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        88..108
FT                   /note="Helical; Name=Segment S0"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        109..179
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        180..200
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        201..215
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        216..236
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        237..240
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        241..261
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        262..265
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        266..286
FT                   /note="Helical; Voltage-sensor; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        287..301
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        302..322
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        323..336
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        337..359
FT                   /note="Pore-forming; Name=P region"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        360..368
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        369..389
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        390..1209
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          408..550
FT                   /note="RCK N-terminal 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00543"
FT   DOMAIN          786..930
FT                   /note="RCK N-terminal 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00543"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          42..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          557..577
FT                   /note="Segment S7"
FT   REGION          614..634
FT                   /note="Segment S8"
FT   REGION          682..686
FT                   /note="Heme-binding motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q12791"
FT   REGION          704..734
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          784..804
FT                   /note="Segment S9"
FT   REGION          1006..1026
FT                   /note="Segment S10"
FT   REGION          1160..1209
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           353..356
FT                   /note="Selectivity for potassium"
FT   MOTIF           977..999
FT                   /note="Calcium bowl"
FT                   /evidence="ECO:0000250|UniProtKB:B7ZC96"
FT   COMPBIAS        713..731
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1160..1191
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1192..1209
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         440
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000305"
FT   BINDING         463
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000305"
FT   BINDING         465
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000305"
FT   BINDING         986
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:B7ZC96"
FT   BINDING         989
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:B7ZC96"
FT   BINDING         992
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:B7ZC96"
FT   BINDING         994
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000250|UniProtKB:B7ZC96"
FT   MOD_RES         710
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08460"
FT   MOD_RES         712
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         725
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08460"
FT   MOD_RES         729
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08460"
FT   MOD_RES         917
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q08460"
FT   MOD_RES         925
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         929
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1195
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28204"
FT   MOD_RES         1198
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q28204"
FT   LIPID           119
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12791"
FT   LIPID           120
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12791"
FT   LIPID           122
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12791"
FT   VAR_SEQ         1..30
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10384881,
FT                   ECO:0000303|PubMed:16166559, ECO:0000303|PubMed:9403560,
FT                   ECO:0000303|Ref.4, ECO:0000303|Ref.7"
FT                   /id="VSP_009970"
FT   VAR_SEQ         181
FT                   /note="L -> AFERSSLLARISIQKDGCQCVLFSSHFMPRLLM (in isoform
FT                   7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_009971"
FT   VAR_SEQ         644..647
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:16166559,
FT                   ECO:0000303|PubMed:9403560, ECO:0000303|Ref.4,
FT                   ECO:0000303|Ref.7"
FT                   /id="VSP_009973"
FT   VAR_SEQ         703
FT                   /note="L -> LIYSKMSIYKRMSRACCFDCGRSERDCSCMSGRVRGNVDTLERNFPL
FT                   SSVSVNDCSTSFRAF (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_009974"
FT   VAR_SEQ         949..975
FT                   /note="Missing (in isoform 2, isoform 3, isoform 4, isoform
FT                   5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:10384881,
FT                   ECO:0000303|PubMed:16166559, ECO:0000303|PubMed:9403560,
FT                   ECO:0000303|Ref.3, ECO:0000303|Ref.4, ECO:0000303|Ref.7"
FT                   /id="VSP_009976"
FT   VAR_SEQ         1128..1165
FT                   /note="RYVITNPPYEFELVPTDLIFCLMQFDHNAGQSRASLSH -> SNRRCWWFSK
FT                   RQDIHQQKRNGLQMRRIMPIPETFKSSP (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.7"
FT                   /id="VSP_009978"
FT   VAR_SEQ         1166..1209
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.7"
FT                   /id="VSP_009979"
FT   VAR_SEQ         1203..1209
FT                   /note="KKEMVYR -> NNRRCWWFSKRQDIHQQKRNGLQMRRIMPIPETFKSSP
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_009982"
FT   MUTAGEN         685..686
FT                   /note="CH->SR: Loss of heme-induced channel inhibition as
FT                   well as carbon monoxide-induced channel activation."
FT                   /evidence="ECO:0000269|PubMed:16166559"
FT   CONFLICT        33
FT                   /note="Missing (in Ref. 1; AAB51398 and 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        132
FT                   /note="I -> V (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158
FT                   /note="G -> V (in Ref. 5; AAC32866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        164
FT                   /note="K -> E (in Ref. 1; AAB51398)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        176
FT                   /note="L -> P (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        205
FT                   /note="E -> Q (in Ref. 5; AAC32866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        238
FT                   /note="N -> K (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        266
FT                   /note="N -> D (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        279
FT                   /note="R -> I (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        281
FT                   /note="I -> V (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="I -> S (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        296
FT                   /note="S -> N (in Ref. 7; AAP82450)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        338
FT                   /note="L -> P (in Ref. 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        353
FT                   /note="T -> A (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        364
FT                   /note="T -> S (in Ref. 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        364
FT                   /note="T -> TLGT (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        446
FT                   /note="N -> S (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        450
FT                   /note="N -> D (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        468
FT                   /note="Q -> K (in Ref. 1; AAB51398)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        470
FT                   /note="S -> P (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        479
FT                   /note="R -> T (in Ref. 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        549
FT                   /note="A -> S (in Ref. 5; AAC32866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        552
FT                   /note="L -> H (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        553
FT                   /note="A -> V (in Ref. 6; AAP82454)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        600
FT                   /note="N -> T (in Ref. 1; AAB51398)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        605
FT                   /note="E -> G (in Ref. 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        637
FT                   /note="K -> R (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        659
FT                   /note="I -> T (in Ref. 3; AAB96356)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        660
FT                   /note="Q -> R (in Ref. 1; AAB51398)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        677
FT                   /note="R -> K (in Ref. 1; AAB51398)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        685..687
FT                   /note="CHD -> YHE (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        734
FT                   /note="R -> K (in Ref. 2; AAD34786)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        739
FT                   /note="L -> S (in Ref. 6; AAP82454)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        762
FT                   /note="F -> L (in Ref. 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        780
FT                   /note="A -> V (in Ref. 6; AAP82454)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        806
FT                   /note="N -> NRN (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        864
FT                   /note="I -> L (in Ref. 5; AAC32866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        885
FT                   /note="L -> V (in Ref. 5; AAC32866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        940
FT                   /note="I -> T (in Ref. 6; AAP82453)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        989
FT                   /note="D -> G (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1005
FT                   /note="P -> L (in Ref. 4; AAA99161)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1012
FT                   /note="F -> S (in Ref. 5; AAC32866)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1093
FT                   /note="Y -> C (in Ref. 7; AAP82452)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1107
FT                   /note="L -> F (in Ref. 7; AAP82451)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1173
FT                   /note="S -> P (in Ref. 6; AAP82453)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1188
FT                   /note="N -> S (in Ref. 6; AAP82454)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1203
FT                   /note="K -> NR (in Ref. 1; AAB51398, 2; AAD34786, 6;
FT                   AAP82454 and 7; AAP82451)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1209 AA;  134374 MW;  14F19072DA7F22FE CRC64;
     MANGGGGGGG GSSGSSGGGG GGGGGETALR MSSNIHANHL SLDASSSSSS SSSSSSSSSS
     SVHEPKMDAL IIPVTMEVPC DSRGQRMWWA FLASSMVTFF GGLFIILLWR TLKYLWTVCC
     HCGGKTKEAQ KINNGSSQAD GTLKPVDEKE EVVAAEVGWM TSVKDWAGVM ISAQTLTGRV
     LVVLVFALSI GALVIYFIDS SNPIESCQNF YKDFTLQIDM AFNVFFLLYF GLRFIAANDK
     LWFWLEVNSV VDFFTVPPVF VSVYLNRSWL GLRFLRALRL IQFSEILQFL NILKTSNSIK
     LVNLLSIFIS TWLTAAGFIH LVENSGDPWE NFQNNQALTY WECVYLLMVT MSTVGYGDVY
     AKTTLGRLFM VFFILGGLAM FASYVPEIIE LIGNRKKYGG SYSAVSGRKH IVVCGHITLE
     SVSNFLKDFL HKDRDDVNVE IVFLHNISPN LELEALFKRH FTQVEFYQGS VLNPHDLARV
     KIESADACLI LANKYCADPD AEDASNIMRV ISIKNYHPKI RIITQMLQYH NKAHLLNIPS
     WNWKEGDDAI CLAELKLGFI AQSCLAQGLS TMLANLFSMR SFIKIEEDTW QKYYLEGVSN
     EMYTEYLSSA FVGLSFPTVC ELCFVKLKLL MIAIEYKSAN RESRSRKRIL INPGNHLKIQ
     EGTLGFFIAS DAKEVKRAFF YCKACHDDVT DPKRIKKCGC RRLEDEQPPT LSPKKKQRNG
     GMRNSPNTSP KLMRHDPLLI PGNDQIDNMD SNVKKYDSTG MFHWCAPKEI EKVILTRSEA
     AMTVLSGHVV VCIFGDVSSA LIGLRNLVMP LRASNFHYHE LKHIVFVGSI EYLKREWETL
     HNFPKVSILP GTPLSRADLR AVNINLCDMC VILSANQNNI DDTSLQDKEC ILASLNIKSM
     QFDDSIGVLQ ANSQGFTPPG MDRSSPDNSP VHGMLRQPSI TTGVNIPIIT ELAKPGKLPL
     VSVNQEKNSG THILMITELV NDTNVQFLDQ DDDDDPDTEL YLTQPFACGT AFAVSVLDSL
     MSATYFNDNI LTLIRTLVTG GATPELEALI AEENALRGGY STPQTLANRD RCRVAQLALL
     DGPFADLGDG GCYGDLFCKA LKTYNMLCFG IYRLRDAHLS TPSQCTKRYV ITNPPYEFEL
     VPTDLIFCLM QFDHNAGQSR ASLSHSSHSS QSSSKKSSSV HSIPSTANRP NRPKSRESRD
     KQKKEMVYR
//
